日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase transitions, Dirac and Weyl semimetal states in Mn(1-x)Ge(x)Bi(2)Te(4)

Mn(1-x)Ge(x)Bi(2)Te(4)中的相变、狄拉克和外尔半金属态

Shikin, A M; Zaitsev, N L; Estyunina, T P; Estyunin, D A; Rybkin, A G; Glazkova, D A; Klimovskikh, I I; Eryzhenkov, A V; Kokh, K A; Golyashov, V A; Tereshchenko, O E; Ideta, S; Miyai, Y; Kumar, Y; Iwata, T; Kosa, T; Kuroda, K; Shimada, K; Tarasov, A V

Effects of lactose content in milk replacer on apparent digestibility, growth, liver messenger RNA expression, and blood parameters related to metabolism of dairy calves

乳糖含量对奶牛犊表观消化率、生长、肝脏信使RNA表达及代谢相关血液参数的影响

Fukumori, R; Hirose, M; Norimura, I; Nakayama, T; Shimada, K; Mineo, H; Steele, M A; Gondaira, S; Higuchi, H; Chisato, K; Oikawa, S; Izumi, K

Reversal of freshening trend of Antarctic Bottom Water in the Australian-Antarctic Basin during 2010s

2010年代澳大利亚-南极海盆南极底层水淡化趋势的逆转

Aoki, S; Yamazaki, K; Hirano, D; Katsumata, K; Shimada, K; Kitade, Y; Sasaki, H; Murase, H

Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer

胰腺癌胰十二指肠切除术中仅在必要时切除门静脉的可行性

Kishi, Y; Nara, S; Esaki, M; Hiraoka, N; Shimada, K

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

S-1联合伊立替康加贝伐单抗对比mFOLFOX6或CapeOX联合贝伐单抗作为转移性结直肠癌患者一线治疗方案(TRICOLORE):一项随机、开放标签、III期非劣效性试验

Yamada, Y; Denda, T; Gamoh, M; Iwanaga, I; Yuki, S; Shimodaira, H; Nakamura, M; Yamaguchi, T; Ohori, H; Kobayashi, K; Tsuda, M; Kobayashi, Y; Miyamoto, Y; Kotake, M; Shimada, K; Sato, A; Morita, S; Takahashi, S; Komatsu, Y; Ishioka, C

Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer

雌激素受体β基因变异与局部晚期胃癌患者的总生存期

Sunakawa, Y; Cao, S; Berger, M D; Matsusaka, S; Yang, D; Zhang, W; Ning, Y; Parekh, A; Stremitzer, S; Mendez, A; Okazaki, S; Wakatsuki, T; Azuma, M; Shimada, K; Watanabe, M; Koizumi, W; Wu, A H; Lenz, H-J

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer

一项随机II期研究,比较S-1联合口服亚叶酸钙与S-1单药治疗吉西他滨难治性晚期胰腺癌患者的疗效

Ueno, M; Okusaka, T; Omuro, Y; Isayama, H; Fukutomi, A; Ikeda, M; Mizuno, N; Fukuzawa, K; Furukawa, M; Iguchi, H; Sugimori, K; Furuse, J; Shimada, K; Ioka, T; Nakamori, S; Baba, H; Komatsu, Y; Takeuchi, M; Hyodo, I; Boku, N

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

复发/难治性原发性纵隔大B细胞淋巴瘤采用大剂量化疗联合自体干细胞移植治疗

Aoki, T; Shimada, K; Suzuki, R; Izutsu, K; Tomita, A; Maeda, Y; Takizawa, J; Mitani, K; Igarashi, T; Sakai, K; Miyazaki, K; Mihara, K; Ohmachi, K; Nakamura, N; Takasaki, H; Kiyoi, H; Nakamura, S; Kinoshita, T; Ogura, M

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer

肿瘤内三级淋巴器官是胰腺癌患者的良好预后指标

Hiraoka, N; Ino, Y; Yamazaki-Itoh, R; Kanai, Y; Kosuge, T; Shimada, K

Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells

p53 的表达协同增强了胰腺癌细胞中复制型腺病毒诱导的 caspase 介导的细胞凋亡

Y Takei, S Okamoto, K Kawamura, Y Jiang, T Morinaga, M Shingyoji, I Sekine, S Kubo, Y Tada, K Tatsumi, H Shimada, K Hiroshima, N Yamaguchi, M Tagawa